Skin samples produced 92% sensitivity and 22% specificityfor the use of α-syn-SAAs in the distinction of PD versus MSA patients, whereas OM samples produced 55% sensitivity and 50% specificity. The gene discussed is PCSK1N; the disease is Parkinson disease.